Analyst Aaron Grey sees potential cash flow benefits for cannabis companies from reclassification, aiding balance sheets, capital expenditures, or M&A. However, Nadine Sarwat suggests producers and investors would prefer a full de-scheduling and commercial model like alcohol.

Zuanic & Associates find four cannabis stocks undervalued, predicting solid performance amidst uncertain US federal marijuana legalization. The stocks show promise due to operations, growth avenues, valuation, and market position.

Canopy Growth UP 40%: weed stocks have popped off. What's causing the buzz?
In 2023, one in three people can buy weed legally in the U.S., most without a medical card. The country went green in the early twenties, and while states like New Jersey and New York following in the footsteps of crunchier states like Colorado and Oregon, Legal Weed Stocks rose in popularity.
Popularity aside, weed businesses faced a hurdle on a national scale: Wall Street quickly realized that sel...